Authors:
KEHNE JH
KANE JM
CHANEY SF
HURST G
MCCLOSKEY TC
PETTY MA
SENYAH Y
WOLF HH
ZOBRIST R
WHITE HS
Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF MDL-27,192 AS A POTENTIAL BROAD-SPECTRUM ANTICONVULSANT AGENT WITH NEUROPROTECTIVE PROPERTIES, Epilepsy research, 27(1), 1997, pp. 41-54
Authors:
KUDLACZ EM
KNIPPENBERG RW
SHATZER SA
KEHNE JH
MCCLOSKEY TC
BURKHOLDER TP
Citation: Em. Kudlacz et al., THE PERIPHERAL NK-1 NK-2-RECEPTOR ANTAGONIST MDL-105,172A INHIBITS TACHYKININ-MEDIATED RESPIRATORY EFFECTS IN GUINEA-PIGS/, Journal of autonomic pharmacology, 17(2), 1997, pp. 109-119
Authors:
BARON BM
HARRISON BL
KEHNE JH
SCHMIDT CJ
VANGIERSBERGEN PLM
WHITE HS
SIEGEL BW
SENYAH Y
MCCLOSKEY TC
FADAYEL GM
TAYLOR VL
MURAWSKY MK
NYCE P
SALITURO FG
Citation: Bm. Baron et al., PHARMACOLOGICAL CHARACTERIZATION OF MDL-105,519, AN NMDA RECEPTOR GLYCINE SITE ANTAGONIST, European journal of pharmacology, 323(2-3), 1997, pp. 181-192
Authors:
KEHNE JH
PADICH RA
MCCLOSKEY TC
TAYLOR VL
SCHMIDT CJ
Citation: Jh. Kehne et al., 5-HT MODULATION OF AUDITORY AND VISUAL SENSORIMOTOR GATING .1. EFFECTS OF 5-HT RELEASERS ON SOUND AND LIGHT PREPULSE INHIBITION IN WISTAR RATS, Psychopharmacology, 124(1-2), 1996, pp. 95-106
Citation: Ra. Padich et al., 5-HT MODULATION OF AUDITORY AND VISUAL SENSORIMOTOR GATING .2. EFFECTS OF THE 5-HT2A ANTAGONIST MDL-100,907 ON DISRUPTION OF SOUND AND LIGHT PREPULSE INHIBITION PRODUCED BY 5-HT AGONISTS IN WISTAR RATS, Psychopharmacology, 124(1-2), 1996, pp. 107-116
Authors:
KEHNE JH
KETTELER HJ
MCCLOSKEY TC
SULLIVAN CK
DUDLEY MW
SCHMIDT CJ
Citation: Jh. Kehne et al., EFFECTS OF THE SELECTIVE 5-HT2A RECEPTOR ANTAGONIST MDL-100,907 ON MDMA-INDUCED LOCOMOTOR STIMULATION IN RATS, Neuropsychopharmacology, 15(2), 1996, pp. 116-124
Authors:
KEHNE JH
BARON BM
CARR AA
CHANEY SF
ELANDS J
FELDMAN DJ
FRANK RA
VANGIERSBERGEN PLM
MCCLOSKEY TC
JOHNSON MP
MCCARTY DR
POIROT M
SENYAH Y
SIEGEL BW
WIDMAIER C
Citation: Jh. Kehne et al., PRECLINICAL CHARACTERIZATION OF THE POTENTIAL OF THE PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100,907 AS A POTENT 5-HT2A ANTAGONIST WITH A FAVORABLE CNS SAFETY PROFILE, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 968-981
Citation: Jh. Kehne et al., DOPAMINERGIC, GLUTAMATERGIC, AND SEROTONERGIC MODULATION OF SENSORY GATING - USE OF PREPULSE INHIBITION FOR EVALUATING ANTIPSYCHOTIC ACTIVITY AND PSYCHOTOMIMETIC POTENTIAL OF NOVEL THERAPEUTIC COMPOUNDS, Schizophrenia research, 15(1-2), 1995, pp. 154-154
Authors:
KEHNE JH
BARON BM
HARRISON BL
MCCLOSKEY TC
PALFREYMAN MG
POIROT M
SALITURO FG
SIEGEL BW
SLONE AL
VANGIERSBERGEN PLM
WHITE HS
Citation: Jh. Kehne et al., MDL-100,458 AND MDL-102,288 - 2 POTENT AND SELECTIVE GLYCINE RECEPTORANTAGONISTS WITH DIFFERENT FUNCTIONAL PROFILES, European journal of pharmacology, 284(1-2), 1995, pp. 109-118
Authors:
KANE JM
STAEGER MA
DALTON CR
MILLER FP
DUDLEY MW
OGDEN AML
KEHNE JH
KETTELER HJ
MCCLOSKEY TC
SENYAH Y
CHMIELEWSKI PA
MILLER JA
Citation: Jm. Kane et al., 5-ARYL-3-(ALKYLTHIO)-4H-1,2,4-TRIAZOLES AS SELECTIVE ANTAGONISTS OF STRYCHNINE-INDUCED CONVULSIONS AND POTENTIAL ANTISPASTIC AGENTS, Journal of medicinal chemistry, 37(1), 1994, pp. 125-132
Authors:
SCHMIDT CJ
KEHNE JH
CARR AA
FADAYEL GM
HUMPHREYS TM
KETTLER HJ
MCCLOSKEY TC
PADICH RA
TAYLOR VL
SORENSEN SM
Citation: Cj. Schmidt et al., CONTRIBUTION OF SEROTONIN NEUROTOXINS TO UNDERSTANDING PSYCHIATRIC-DISORDERS - THE ROLE OF 5-HT2 RECEPTORS IN SCHIZOPHRENIA AND ANTIPSYCHOTIC ACTIVITY, International clinical psychopharmacology, 8, 1993, pp. 25-32